Impact of Different Helicobacter pylori Eradication Therapies on Gastrointestinal Symptoms

被引:5
|
作者
Mestrovic, Antonio [1 ]
Bozic, Josko [2 ]
Vukojevic, Katarina [3 ]
Tonkic, Ante [1 ,4 ]
机构
[1] Univ Hosp Split, Dept Gastroenterol, Split 21000, Croatia
[2] Univ Split, Sch Med, Dept Pathophysiol, Split 21000, Croatia
[3] Univ Split, Sch Med, Dept Anat, Split 21000, Croatia
[4] Univ Split, Sch Med, Dept Internal Med, Split 21000, Croatia
来源
MEDICINA-LITHUANIA | 2021年 / 57卷 / 08期
关键词
Helicobacter pylori; eradication therapy; quality of life; Gastrointestinal Symptom Rating Scale; hybrid therapy; concomitant therapy; QUALITY-OF-LIFE; FUNCTIONAL DYSPEPSIA; RATING-SCALE; INFECTION; PREVALENCE; IMPROVEMENT;
D O I
10.3390/medicina57080803
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Helicobacter pylori (H. pylori) infection impairs quality of life. However, whether eradication therapy ameliorates gastrointestinal symptoms remains questionable. The main objective of this study was to evaluate the influence of H. pylori eradication therapy on gastrointestinal symptoms. Materials and Methods: A total of 140 patients, 59 women and 81 men, with a mean age of 61 and suffering from H. pylori infection in the University Hospital of Split, Croatia, were enrolled in the study. Patients were randomly assigned to either concomitant or hybrid therapies. The Gastrointestinal Symptom Rating Scale (GSRS) questionnaire was completed by patients prior to and after the eradication therapy. Results: In both groups, the total GSRS score improved significantly after therapy. In the concomitant group, the abdominal pain score, reflux symptoms score and indigestion score decreased significantly after therapy. In the group with hybrid therapy, all five groups of symptoms (abdominal pain, reflux symptoms, indigestion, diarrhea and constipation) significantly decreased after therapy. Patients with adverse events had significantly higher total GSRS scores after eradication therapy. Conclusions: H. pylori eradication therapy could alleviate gastrointestinal symptoms regardless of the treatment used, but the favorable effect seemed to be more pronounced after hybrid therapy.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Use of different therapies for Helicobacter pylori eradication in children
    Canedo, E.
    Urruzuno, P.
    Martinez-Gomez, M.
    Ruiz-Bermejo, M.
    Donado, P.
    Alarcon, T.
    Lopez-Brea, M.
    [J]. HELICOBACTER, 2006, 11 (04) : 379 - 379
  • [2] Eradication therapies for Helicobacter pylori
    Borody, TJ
    Shortis, NP
    Reyes, E
    [J]. JOURNAL OF GASTROENTEROLOGY, 1998, 33 : 53 - 56
  • [3] The Impact of Helicobacter pylori Status Following a Course of Eradication Therapy on Common Gastrointestinal Symptoms
    Baker, Jason
    Chey, William D.
    Kao, John Y.
    Saad, Richard J.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S564 - S564
  • [4] Triple therapies plus different probiotics for Helicobacter pylori eradication
    Scaccianoce, G.
    Zullo, A.
    Hassan, C.
    Gentili, F.
    Cristofari, F.
    Cardinale, V.
    Gigliotti, F.
    Piglionica, D.
    Morini, S.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2008, 12 (04) : 251 - 256
  • [5] Novel therapies for Helicobacter pylori eradication
    Montague, S
    O'Morain, C
    [J]. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 1998, 1998, : 441 - 455
  • [6] Optimization of Helicobacter pylori eradication therapies
    Liou, Jyh-Ming
    [J]. ADVANCES IN DIGESTIVE MEDICINE, 2018, 5 (1-2) : 1 - 2
  • [7] Helicobacter pylori eradication - an update on the latest therapies
    Yaxley, Julian
    Chakravarty, Bhaskar
    [J]. AUSTRALIAN FAMILY PHYSICIAN, 2014, 43 (05) : 301 - 305
  • [8] Upper gastrointestinal symptoms after successful eradication of Helicobacter pylori in patients with gastroduodenal ulcer
    Nakashima, S
    Imoto, I
    Nakamura, M
    Inoue, H
    Toyoda, N
    Oka, S
    Taguchi, Y
    Adachi, Y
    [J]. GUT, 2002, 51 : A102 - A102
  • [9] The effect of Saccharomyces boulardii on gastrointestinal symptoms and Helicobacter pylori eradication in patients with functional dyspepsia
    Soykan, I
    Toruner, M
    Temizkan, A
    Ozden, A
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A182 - A182
  • [10] Impact of pharmacogenomics on Helicobacter pylori eradication
    Furuta, Takahisa
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 48 - 48